» Articles » PMID: 20373539

Three-dimensional Architecture and Cell Composition of a Choukroun's Platelet-rich Fibrin Clot and Membrane

Overview
Journal J Periodontol
Date 2010 Apr 8
PMID 20373539
Citations 156
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Platelet-rich fibrin (PRF; Choukroun's technique) is a second-generation platelet concentrate for surgical use. This easy protocol allows the production of leukocyte and platelet-rich fibrin clots and membranes starting from 10-ml blood samples. The purposes of this study were to determine the cell composition and three-dimensional organization of this autologous biomaterial and to evaluate the influence of different collection tubes (dry glass or glass-coated plastic tubes) and compression procedures (forcible or soft) on the final PRF-membrane architecture.

Methods: After centrifugation, blood analyses were performed on the residual waste plasmatic layers after collecting PRF clots. The PRF clots and membranes were processed for examination by light microscopy and scanning electron microscopy.

Results: Approximately 97% of the platelets and >50% of the leukocytes were concentrated in the PRF clot and showed a specific three-dimensional distribution, depending on the centrifugation forces. Platelets and fibrin formed large clusters of coagulation in the first millimeters of the membrane beyond the red blood cell base. The fibrin network was very mature and dense. Moreover, there was no significant difference in the PRF architecture between groups using the different tested collection tubes and compression techniques, even if these two parameters could have influenced the growth factor content and biologic matrix properties.

Conclusions: The PRF protocol concentrated most platelets and leukocytes from a blood harvest into a single autologous fibrin biomaterial. This protocol offers reproducible results as long as the main production principles are respected.

Citing Articles

Antibiotic-Loaded Platelet-Rich Fibrin (AL-PRF) as a New Carrier for Antimicrobials: A Systematic Review of In Vitro Studies.

Niemczyk W, Zurek J, Niemczyk S, Kepa M, Zieba N, Misiolek M Int J Mol Sci. 2025; 26(5).

PMID: 40076763 PMC: 11899807. DOI: 10.3390/ijms26052140.


Regenerative potential of concentrated growth factor compared to platelet-rich fibrin in treatment of necrotic mature teeth: a randomized clinical trial.

Salah T, Hussein W, Abdelkafy H BDJ Open. 2025; 11(1):10.

PMID: 39900647 PMC: 11790909. DOI: 10.1038/s41405-024-00288-3.


Autologous platelet concentrates as adjuncts to non-surgical periodontal therapy: a systematic review and meta-analysis.

Lipovec T, Kapadia N, Antonoglou G, Lu E, El-Sayed K, Nibali L Clin Oral Investig. 2025; 29(1):74.

PMID: 39841297 PMC: 11754314. DOI: 10.1007/s00784-024-06128-w.


First- vs. Second-Generation Autologous Platelet Concentrates and Their Implications for Wound Healing: Differences in Proteome and Secretome.

Stiller H, Perumal N, Manicam C, Trzeciak E, Todt J, Jurk K Bioengineering (Basel). 2024; 11(11).

PMID: 39593831 PMC: 11591784. DOI: 10.3390/bioengineering11111171.


Use of Autologous Leukocyte-Platelet Rich Fibrin (L-PRF) in Endoscopic Anterior Skull Base Defect Repair-A Newer Graft Material: Name of Authors.

Yadav R, Chaudhary A, Gupta D, Saroj S, Singh V, Kumar R Indian J Otolaryngol Head Neck Surg. 2024; 76(6):5618-5622.

PMID: 39559155 PMC: 11569114. DOI: 10.1007/s12070-024-05046-3.